Brought to you by 
NxStage Medical completes $58.8mm IPO
10 Nov 2005
Executive Summary
NxStage Medical (develops, manufactures, and markets devices to treat end-stage renal disease and acute kidney failure) has netted $58.8mm in its initial public offering, selling 6.33mm shares at $10 each--including the overallotment. It had originally hoped to bring in up to $75mm.
Deal Industry
- Medical Devices
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
NxStage Medical completes $58.8mm IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice